Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GUD.TOthis companyKnight Therapeutics Inc.	CA$11.58	-112.04×	0.79×	1.34×	11.11×	-352.6%	33.5%	-0.5%	-1.2%	-0.7%	-0.2%	11.4%	0.1×	0.03×	-0.21×	2.39×	0.0%	7	3.8	3	B-
ACB.TOAurora Cannabis Inc.	CA$7.44	-2.13×	0.51×	0.81×	-1.15×	-669.8%	5.2%	-50.8%	-38.0%	-23.8%	-30.2%	-13.9%	0.05×	0.6×	-89.99×	5.94×	0.0%	1	-12.15	2	C+
CPH.TOCipher Pharmaceuticals Inc.	CA$13.57	10.06×	2.22×	5.44×	11.52×	423.7%	65.8%	32.7%	54.2%	22.1%	12.8%	10.8%	0.04×	-0.08×	14.17×	1.12×	0.0%	6	9.06	5	S-
OGI.TOOrganigram Global Inc.	CA$1.26	-14.84×	1.03×	1.39×	-13.88×	-3094.3%	3.7%	-34.1%	-9.6%	-7.1%	-13.0%	-6.8%	0.03×	3.64×	0×	2.26×	0.0%	5	-0.07	4	A
TSND.TOTerrAscend Corp.	CA$0.67	-2.49×	2.23×	0.82×	6.93×	-343.4%	50.2%	17.1%	-33.1%	-90.2%	-44.2%	6.1%	2.64×	3.48×	1.23×	1.38×	0.0%	5	-1.18	1	C-
VHI.TOVitalhub Corp.	CA$7.93	94.7×	2.08×	5.09×	29.28×	92.9%	70.2%	11.2%	5.6%	2.3%	4.2%	1.4%	0.01×	-3.23×	172.98×	2.4×	0.0%	5	3.51	3	B+
Peer median	—	-2.13×	2.08×	1.39×	6.93×	-343.4%	50.2%	11.2%	-9.6%	-7.1%	-13.0%	1.4%	0.04×	0.6×	1.23×	2.26×	0.0%	5	-0.07	3	—